Dr. Paul Christopher Adamson, MD, MPH

Dr. Adamson practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Adamson's NPI, 1639558455, was assigned on May 26, 2015. Dr. Adamson graduated from UCSF School of Medicine in 2015. Dr. Adamson's California license number on file is A154218.

Dr. Adamson's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Adamson's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Adamson is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Adamson to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adamson practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Adamson's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Adamson is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Adamson's licenses on file in 2 states: California and Connecticut.

CMS data shows 131 Medicare services from Dr. Adamson across 2 procedure codes in 2024, for 53 Medicare patients. Medicare paid $13,843 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Adamson in 2024. The largest group is under 65, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 5.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adamson's median patient age at 51, with 30% women.

In 2024, Dr. Adamson wrote 42 Medicare Part D claims for 11 patients. 52% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $71,745 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Adamson for performance year 2024, reported as part of a group. Dr. Adamson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Adamson in 2012. Dr. Adamson's most frequent co-author is Alexandra Holly Freeman, MD.

CMS Open Payments shows 5 general payments to Dr. Adamson from 3 drug and device companies from 2021 to 2024. Consulting fees make up the largest share, 71% of the total. Abbott Laboratories paid the most, $700.

Dr. Adamson graduated from UCSF School of Medicine in 2015.

Dr. Adamson is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.